Table 2A.
Characteristics of surgical treatment of the total patient population.
| Total N = 223 |
Group 1: Primary surgery at tertiary gyn-onc center N = 150 |
Group 2: Primary surgery at non-tertiary center N = 73 |
P-value | |
|---|---|---|---|---|
| Mean number of surgical interventions, N ± SD | 1.6 ± 0.6 | 1.3 ± 0.5 | 2.1 ± 0.3 | <.001 |
| Patients with at least one laparotomy, N (%) | 137 (61.4) | 99 (66) | 38 (52.1) | .032 |
| Mean number of hospitalization days, days ± SD | 11.4 ± 6.3 | 11.1 ± 6.3 | 12.0 ± 6.2 | .369 |
| Surgical cytoreduction, N (%) Yes No |
217 (97.3) 6 (2.7) |
145 (96.7) 5 (3.3) |
72 (98.6) 1 (1.4) |
.666 |
| Mean time from diagnosis until completion of surgical cytoreduction, days ± SD | 45.9 ± 60.7 | 31.9 ± 56.7 | 73.7 ± 59.3 | <.001 |
| Cumulative duration of surgery, minutes ± SD | 326.8 ± 137.1 | 329.4 ± 141.6 | 315.8 ± 116.9 | .609 |
| Cumulative blood loss, ml ± SD | 430.7 ± 435.0 | 456.6 ± 412.3 | 350.2 ± 495.8 | .159 |
| Intraoperative complications, N (%) | 27 (12.1) | 17 (11.3) | 10 (13.7) | .664 |
| Postoperative complications, N (%) | 85 (38.1) | 58 (38.7) | 27 (37.0) | .884 |
| Residual disease, N (%) No cytoreduction performed Complete cytoreduction Minimal residual disease Macroscopic residual disease |
6 (2.7) 203 (91.0) 11 (4.9) 3 (1.3) |
5 (3.3) 135 (90.0) 8 (5.3) 2 (1.3) |
1 (1.4) 68 (93.2) 3 (4.1) 1 (1.4) |
.719 |
A statistically significant p-value lower than 0.05 is marked bold in the table. N, number; SD, standard deviation; ml, milliliter.